Skip to content
Medical Health Aged Care

Andrew Denton marks decade of Voluntary Assisted Dying reform with new research fund

Go Gentle Australia 3 mins read
Key Facts:
  • Founder of Go Gentle Australia delivers National Press Club address 10 years after launching national campaign for VAD laws 
  • Legislation in every state and territory represents a profound shift in both law and medical culture. Thousands of Australians have now accessed VAD
  • New Research Fund to investigate unresolved issues such as VAD access for people with dementia and obstruction of the VAD choice

Canberra, 7 October – Ten years after launching Go Gentle Australia at the National Press Club (NPC), founder Andrew Denton has returned to mark a transformation in end-of-life care and warn that the work of voluntary assisted dying reform is far from finished.

When Denton first called for change in 2016, more than 50 attempts to pass voluntary assisted dying (VAD) laws in Australian parliaments had failed. Today, every state and territory has passed legislation allowing eligible terminally ill people to seek medical assistance to die.

“Back then, it seemed impossible,” Denton said. Yet over the following decade, sustained public advocacy and parliamentary reform transformed VAD from a politically contentious proposal into a legal end-of-life option across Australia.

Denton told the National Press Club the reforms represented a profound shift in both law and medical culture. At least 10,000 Australians have now accessed VAD, while many of the fears raised before legalisation – including that palliative care would be weakened or vulnerable people would be coerced – had not materialised.

But significant barriers remain.

Among the most pressing is obstruction by hospitals and aged care providers that object to VAD. Denton described distressing cases where seriously ill patients had been required to leave hospitals for assessments, prevented from receiving VAD care on site, or forced to choose between remaining in a facility for their medical care or continuing their VAD application.

Go Gentle research into aged care found only seven of 70 major providers offered residents both comprehensive information and full access to VAD.

Denton called for stronger protections to ensure institutions that conscientiously object do not prevent patients from exercising their legal rights, including allowing external VAD practitioners to enter hospitals and providing neutral spaces where assessments and other parts of the process can take place.

He also highlighted one of the most difficult questions facing VAD policy: whether people diagnosed with dementia should ever be able to access assisted dying.

Currently, Australian VAD laws require a person to retain decision-making capacity throughout the process, effectively excluding people once dementia has progressed beyond a certain point.

“Ethically, medically, legally and politically this is as complex as it gets,” Denton said. “Saying ‘too hard’ is not an option.”

To help address these and other unresolved issues, Denton announced the establishment of the Go Gentle VAD Research Fund, designed to produce evidence that can drive policy reform, advocacy and education.

Its first project will examine VAD practitioners’ attitudes towards access for people with dementia and the safeguards that would be required. A second project will investigate institutional obstruction, including where it occurs and how it affects patients.

“The research it enables will be chosen specifically for its ability to drive change, through evidence, advocacy, and education,” Denton said.

After a decade spent securing VAD laws across Australia, Go Gentle’s next task is ensuring those laws deliver fair and meaningful access.

The goal, Denton said, remains giving every Australian “the chance of a good death” and “the choice not to suffer”.

Read the full NPC speech


About us:

Go Gentle was founded by Andrew Denton in 2016. We are a national charity that supports choice at the end of life, including the option of voluntary assisted dying. We have been instrumental in passing voluntary assisted dying laws in all six states, the ACT and the Northern Territory and are now focused on supporting improvements to VAD care.


Contact details:

Email: [email protected]  Phone: 0426283865

Media

More from this category

  • Medical Health Aged Care
  • 07/10/2026
  • 11:08
Palliative Care Australia

Palliative Care Australia calls for nominations to honour excellence in palliative care

Palliative Care Australia (PCA) is calling for nominations for the 2027 National Palliative Care Awards, recognising the people and organisations making a difference in…

  • Contains:
  • Medical Health Aged Care
  • 07/10/2026
  • 10:16
Monash University

First Monash cohort ready to join Victoria’s growing pharmacist prescribing workforce

More than 120 students graduating from Monash University’s Graduate Certificate of Pharmacist Prescribing this year are poised to help patients access care across the state, as the Victorian Government today adds new conditions to the Chemist Care Now Community Pharmacist Program. The Faculty of Pharmacy and Pharmaceutical Sciences Graduate Certificate, which launched last year in response to the evolving responsibilities of pharmacists, directly supports the Victorian Government’s Chemist Care Now program, training pharmacists to deliver even better quality of care to their patients. Health Minister Ingrid Stitt today visited TerryWhite Chemmart Footscray to announce two new conditions will join the…

  • Medical Health Aged Care
  • 06/10/2026
  • 21:22
Invivoscribe

Invivoscribe® Advances Molecular Clonality Testing Portfolio with Comprehensive LymphoTrack® Flex Suite

New ultra-high sensitivity tests enable objective, automation-ready, high-throughput clonality and MRD workflow. SAN DIEGO–BUSINESS WIRE– Invivoscribe, a global leader in precision diagnostics and measurable…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.